glp-1 obesity drug news oct 21 2025 Why drugs are changing the future of metabolic health Trump plan on weight loss
Description
Zepbound if prescribed for obstructive sleep apnea in adults with obesity
A GLP-1 receptor agonist is a medication that mimics the function of GLP-1 (glucagon-like peptide-1), which is a naturally occurring gut hormone
In healthy individuals, the incretin effect stimulates insulin secretion, accounting for about 70% of total insulin secretion, with GIP contributing two-thirds of this effect, which is higher than that of GLP-1
However, the natural GLP-1 has a very short half-life, lasting only 1-2 minutes in the bloodstream
Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, et al
